Yang Z, Dai Y, Li Y, Xia L, et al. Routine biomarkers map response probability in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2 blockade. BMC Cancer 2026 Jul 2. doi: 10.1186/s12885-026-16403.
PMID: 42393615